XENON XE 127
LOE Approachingxenon xe-127
NDAINHALATIONGAS
Approved
Oct 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 22h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
XENON XE-127 is an inhalational xenon gas approved since 1982 for diagnostic and therapeutic applications. The mechanism of action and specific indications are not detailed in available data, but xenon gases are commonly used in medical imaging and anesthesia. This is a legacy product with a well-established clinical profile.
LOE Approaching
Approaching loss of exclusivity with moderate competitive pressure (30%) signals smaller, defensive brand team focused on protecting remaining market share.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
With 24 linked job openings, this product supports a lean but senior-focused team structure typical of mature products approaching LOE. Career opportunities emphasize leadership, strategic planning, and organizational support rather than front-line commercial roles.
Director/Senior DirectorDirector
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.